Location of Repository

Small Cell Lung Cancer Doubling Time and its Effect on Clinical Presentation: A Concise Review

By Kassem Harris, Inga Khachaturova, Basem Azab, Theodore Maniatis, Srujitha Murukutla, Michel Chalhoub, Hassan Hatoum, Thomas Kilkenny, Dany Elsayegh, Rabih Maroun and Homam Alkaied

Abstract

Small cell lung cancer (SCLC) is one of many types rapidly growing malignant diseases, such as Burkitt’s lymphoma and testicular germ cell cancers. At present, there is no reliable way to screen for SCLC, and imaging modalities tend to be delayed in detecting this type of cancer. The clinical presentation of acutely and rapidly growing SCLC can mimic those of pulmonary inflammatory or infectious disorders, and in some instances, this delays appropriate management and negatively affects patient outcome

Topics: Rapid Communication
Publisher: Libertas Academica
OAI identifier: oai:pubmedcentral.nih.gov:3355865
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. Actual growth rate and tumour cell proliferation in human pulmonary neoplasms.
    2. (1994). AraiT,KuroishiT,SaitoY,KuritaY,NarukeT,KanekoM.Tumor doubling timeandprognosisinlungcancerpatients:evaluationfromchestfilms and clinical follow-up study. Japanese Lung Cancer Screening Research Group.
    3. (2011). Clinical Dutch-English Lambert-Eaton Myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS.
    4. Clinical practice. The solitary pulmonary nodule. The New England
    5. (2011). Cost-effectiveness of computed tomography screening for lung cancer in the United States.
    6. (2007). CT findingsofearly-stagesmallcelllungcancerinalow-doseCTscreening programme. Lung Cancer
    7. FA. Characteristics and outcomes of small cell lung cancer patients diagnosed during two lung cancer computed tomographic screening programs in heavy smokers.
    8. (2001). HasegawaM,SoneS,TakashimaS,LiF,YangZG,MaruyamaY,etal. Growth rate of small lung cancers detected on mass CT screening.
    9. (2011). Lung cancer risk prediction to select smokers for screening CT— a model based on the Italian COSMOS trial. Cancer Prevention Research
    10. Reduced lung-cancer mortality with low-dose computed tomographic screening. The New England
    11. (2011). Screening for lung cancer with chest radiographs.
    12. (1994). Small cell lung cancer. State-of-the-art therapy
    13. (2011). Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.
    14. (1996). States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females.
    15. (2005). Ten years of disease-free survival between two diagnoses of small-cell lung cancer: a case report and a literature review. Medical Oncology
    16. (2011). Trends in incidence of small cell lung cancer and all lung cancer. Lung Cancer
    17. (2000). WangJC,SoneS,FengL,YangZG,TakashimaS,MaruyamaY,etal.Rapidly growing small peripheral lung cancers detected by screening CT: correlation between radiological appearance and pathological features.
    18. (2000). WistubaII,BerryJ,BehrensC,MaitraA,ShivapurkarN,MilchgrubS,etal. Molecular changes in the bronchial epithelium of patients with small cell lung cancer. Clinical Cancer Research: An

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.